Skip Navigation
Skip to contents

ICDM 2025

Program details

Main symposia
Diabetes complications 1 Crossing the boundaries of diabetic retinopathy: from pathophysiological insight to integrated care Friday 26 September, 15:00~16:20
Room 3
(Walker hall 1, 1F)
As diabetes continues to rise worldwide, its microvascular complications -especially diabetic retinopathy (DR)- pose an increasing challenge to comprehensive care. DR is now recognized as more than a localized eye disease; it reflects systemic metabolic dysfunction and calls for multidisciplinary collaboration. This cross-specialty session explores the latest insights into DR pathophysiology, advances in diagnostic imaging, and the systemic management strategies that shape retinal outcomes. Bridging basic science and clinical practice, we aim to illuminate new pathways for integrated care in diabetes.
Junyeop Lee S10-L1
Junyeop LeeAsan Medical Center, Korea
Beyond the vessels: emerging pathways in diabetic retinopathy
Sang Jun Park S10-L2
Sang Jun Park, Korea
Revolutionizing DR detection and care: patient-centric digital-empowered platform
Seung Min Chung S10-L3
Seung Min ChungYeungnam University Medical Center, Korea
Managing diabetes for the eye: systemic diabetes management and its retinal implications
Panel discussion
  • Kyung Ae LEE S10-P1
    Kyung Ae LEEJeonbuk National University Hospital, Korea
  • None S10-P2
    , Korea
  • Hae Kyung Kim S10-P3
    Hae Kyung KimYonsei University Severance Hospital, Korea
Diabetes complications 2 Precision medicine of diabetic kidney disease Friday 26 September, 16:30-17:50
Room 3
(Walker hall 1, 1F)
Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease. It is a multifactorial disease. The pathophysiology of DKD and the response to treatment can vary significantly among individuals. As technology advances, we can adopt a more personalized approach to managing DKD. This session will discuss the significance of precision medicine, recent advancements, and effective therapeutic strategies for treatment.
None S09-L1
Petter BjornstadUW Medicine Diabetes Institute, USA
Lessons from human kidney tissue in diabetes
David Cherney S09-L2
David CherneyUniversity of Toronto, Canada, Canada
Therapeutic strategies for DKD
Mi Kyung Kim S09-L3
Mi Kyung KimKeimyung University, Korea, Korea
The many faces of kidney disease in diabetes—not all are diabetic nephropathy
Diabetes complications 3 Diabetes and the brain: emerging links, therapies, and future directions Saturday 27 September, 08:40~10:00
Room 3
(Walker hall 1, 1F)
None S11-L1
예병석연세의대 신경과, Korea
Diabetes and dementia with a focus on Alzheimer's disease and lewy body dementia
Seong Ho Jeong S11-L2
Seong Ho JeongDepartment of Neurology, Yonsei University, Korea
Unraveling the Diabetes-Parkinson's connection with shared pathways and therapeutic insights from antidiabetic agent
Paul Edison S11-L3
Paul EdisonImperial College London, UK
The diabetic brain on imaging
Jin Hwa Kim S11-L4
Jin Hwa KimChosun University Hospital, Korea
From glycemia to cognitive rescue: a new paradigm for treating diabetes and neurodegeneration with GLP-1RA
KDA 대한당뇨병학회Korean Diabetes Association
  • (04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea
  • Tel: +82-2-714-9064 | E-mail: diabetes@kams.or.kr
  • Business Registration Number: 106-82-31108 | Name of Representative: Bong-Soo Cha
Congress Secretariat (Planbear)
  • #1108, 220, Gonghang-daero, Gangseo-gu, Seoul(07806), Republic of Korea
  • Tel. +82-2-6953-0582   E-mail: icdm@diabetes.or.kr